Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 7/20 | 0.64 |
| ▸ | MAOB | P27338 | 5/20 | 0.64 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.60 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.60 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.60 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | F13A1 | P00488 | 1/20 | 0.56 |
| ▸ | TGM2 | P21980 | 1/20 | 0.56 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.52 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.51 |
| ▸ | KLK7 | P49862 | 1/20 | 0.50 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29885475 | 0.94 | MAOA (0.57) | MAOAMAOBLMNASMN1; SMN2ESR2 | |
| SCHEMBL2314134 | 0.84 | OPRD1 (0.62) | MAOAMAOBSMN1; SMN2POLBMAPT | |
| SCHEMBL3366271 | 0.84 | OPRD1 (0.62) | MAOAMAOBSMN1; SMN2POLBMAPT | |
| SCHEMBL29477243 | 0.83 | LMNA (0.50) | MAOAMAOBLMNASMN1; SMN2ESR2 | |
| SCHEMBL24210580 | 0.83 | LMNA (0.79) | MAOAMAOBLMNASMN1; SMN2ESR2 | |
| SCHEMBL10150353 | 0.80 | MKNK2 (0.59) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| SCHEMBL28721233 | 0.80 | CYP19A1 (0.56) | MAOAMAOBLMNASMN1; SMN2ESR2 | |
| SCHEMBL869065 | 0.79 | LMNA (0.88) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| SCHEMBL29737259 | 0.79 | LMNA (0.88) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 | |
| SCHEMBL31217635 | 0.79 | LMNA (0.88) | LMNASMN1; SMN2ESR2ALDH1A1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250368695-A1 | Atranorin biosynthesis gene derived from lichens and uses thereof | INDUSTRY ACADEMIC COOPERATION FOUNDATION OF SUNCHON NATIONAL UNIV (KR) | 2025-12-04 | — | — | US | disclosed |
| EP-3599853-B1 | HERBICIDAL COMPOSITIONS AND METHODS OF USE THEREOF | UNIV CALIFORNIA (US) | 2025-07-30 | — | — | EP | disclosed |
| US-20240043850-A1 | COMPOSITIONS AND METHODS FOR TYPE III POLYKETIDE PRODUCTION IN OLEAGINOUS YEAST SPECIES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2024-02-08 | — | — | US | disclosed |
| US-11820987-B2 | Compositions and methods for type III polyketide production in oleaginous yeast species | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-11-21 | — | — | US | disclosed |
| WO-2022260402-A1 | ATRANORIN BIOSYNTHESIS GENE DERIVED FROM LICHEN AND USE THEREOF | 순천대학교 산학협력단 | 2022-12-15 | — | — | WO | disclosed |
| CN-112915079-A | Application of compound 6-hydroxy meleumycin in preparing anti-tumor medicine | 江西科技师范大学 | 2021-06-08 | — | — | CN | disclosed |
| US-20200037609-A1 | HERBICIDAL COMPOSITIONS AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-02-06 | — | — | US | disclosed |
| EP-3599853-A1 | HERBICIDAL COMPOSITIONS AND METHODS OF USE THEREOF | The Regents of the University of California (US) | 2020-02-05 | — | — | EP | disclosed |
| US-20190078098-A1 | COMPOSITIONS AND METHODS FOR TYPE III POLYKETIDE PRODUCTION IN OLEAGINOUS YEAST SPECIES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2019-03-14 | — | — | US | disclosed |
| CN-109415681-A | For producing the composition and method of type III polyketone in oleaginous yeast kind | 德克萨斯大学系统董事会 | 2019-03-01 | — | — | CN | disclosed |
| WO-2012129450-A1 | MICROBIAL PRODUCTION OF CHEMICAL PRODUCTS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | OPX BIOTECHNOLOGIES, INC. (US) | 2012-09-27 | — | — | WO | disclosed |
| US-8119385-B2 | Nucleic acids and proteins and methods for making and using them | BP CORPORATION NORTH AMERICA INC. (US) | 2012-02-21 | — | — | US | disclosed |
| US-20110296543-A1 | NUCLEIC ACIDS AND PROTEINS AND METHODS FOR MAKING AND USING THEM | THE UNIVERSITY OF CALIFORNIA (US) | 2011-12-01 | — | — | US | disclosed |
| WO-2011094457-A1 | MICROORGANISM PRODUCTION OF HIGH-VALVE CHEMICAL PRODUCTS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | OPX BIOTECHNOLOGIES, INC. (US) | 2011-08-04 | — | — | WO | disclosed |
| US-20100009970-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES | COMBINATORX (SINGAPORE) PTE. LTD. (SG) | 2010-01-14 | — | — | US | disclosed |
| US-20100011456-A1 | Nucleic Acids and Proteins and Methods for Making and Using Them | VERENIUM CORPORATION (US) | 2010-01-14 | — | — | US | disclosed |
| US-20080161324-A1 | Compositions and methods for treatment of viral diseases | EXCRX (SINGAPORE) PTE. LTD. (F.K.A. COMBINATORX (SINGAPORE) PTE LTD.) (SG) | 2008-07-03 | — | — | US | disclosed |
| WO-2008033466-A2 | COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES | COMBINATORX (SINGAPORE) PRE. LTD. (SG) | 2008-03-20 | — | — | WO | disclosed |
| EP-0906114-B1 | ANTIPSORIATIC COMPOSITIONS COMPRISING AN ASPHODELUS EXTRACT, METHOD OF MAKING, AND METHOD OF USING | MOADY SAID (US) | 2002-06-26 | — | — | EP | disclosed |
| EP-1166791-A2 | Antipsoriatic compositions comprising an asphodelus extract, method of making, and method of using | Moady, Said (US) | 2002-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100009970-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES | HTR1A, HTR3B, HTR3A | MAOA 32/4885MAOB 26/4885LMNA 692/4885 |
| US-20080161324-A1 | Compositions and methods for treatment of viral diseases | HAVCR2, EIF2AK2, RNASE1 | MAOA 1703/4885MAOB 996/4885LMNA 624/4885 |
| US-20200037609-A1 | HERBICIDAL COMPOSITIONS AND METHODS OF USE THEREOF | DDT, ASPH, AS3MT | MAOA 775/4885MAOB 698/4885LMNA 3781/4885 |
| US-20100011456-A1 | Nucleic Acids and Proteins and Methods for Making and Using Them | POLN, POLM, POLI | MAOA 674/4885MAOB 1129/4885LMNA 389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.